Blocking the PI3K pathway enhances the efficacy of ALK-targeted therapy in EML4-ALK-positive nonsmall-cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s13277-014-2252-y
Published Online: 2014-06-29
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Lin
Li, Guangchao
Zhao, Likun
Pan, Fei
Qiang, Jiankun
Han, Siqi
Text and Data Mining valid from 2014-06-29